1 / 3
基本信息
财务信息
营业额
未提供
毛利润
未提供
净利润
未提供
月租金
未提供
业务运营、资产与经营场所
卖家职责
一
生意详情
转让原因
NA
生意简介
Profitable, Scalable, significant upside potential.
This business is a leading provider of contract research services and is regarded as an expert in the field of biomarker analysis. They provide a wide range of testing including clinical biomarkers, nucleic acid-based assays, intracellular signalling assays and point-of-care tests. They also provide a range of scientific kits and serum products for clients to undertake their own tests.
Fully Equipped and furnished Lab
Significant pipeline of committed work
Clients include Universities, CROs, Hospitals and Supplement Industry.
Lab to be NATA accredited enabling diversification into Pharma Clinical Trials
$378,000/annum Future Maintainable Earnings (Avg. 2022 + 2023)
Assets with an estimated value of $750,000 included in the purchase price
NATA accreditation (National Association of Testing Authorities) is currently underway and once completed will open a whole new market, including the lucrative pharmaceutical research industry. This is an exciting opportunity for a buyer with ambition and resources to scale this business to its full potential. If you or your organisation have experience managing growth, this opportunity should be investigated.
The current owner would ideally like to keep a stake in the business and participate in its future growth, subject to the skills, reputation and resources of the buyer.
Purchase Price $1,500,000 (includes an estimated $750,000 assets) Plus stock at value
A detailed information memorandum is available to qualified parties, copy and paste this link to complete the confidentiality agreement - https://forms.gle/69qVEPYg5KsB3UVKA
This business is a leading provider of contract research services and is regarded as an expert in the field of biomarker analysis. They provide a wide range of testing including clinical biomarkers, nucleic acid-based assays, intracellular signalling assays and point-of-care tests. They also provide a range of scientific kits and serum products for clients to undertake their own tests.
Fully Equipped and furnished Lab
Significant pipeline of committed work
Clients include Universities, CROs, Hospitals and Supplement Industry.
Lab to be NATA accredited enabling diversification into Pharma Clinical Trials
$378,000/annum Future Maintainable Earnings (Avg. 2022 + 2023)
Assets with an estimated value of $750,000 included in the purchase price
NATA accreditation (National Association of Testing Authorities) is currently underway and once completed will open a whole new market, including the lucrative pharmaceutical research industry. This is an exciting opportunity for a buyer with ambition and resources to scale this business to its full potential. If you or your organisation have experience managing growth, this opportunity should be investigated.
The current owner would ideally like to keep a stake in the business and participate in its future growth, subject to the skills, reputation and resources of the buyer.
Purchase Price $1,500,000 (includes an estimated $750,000 assets) Plus stock at value
A detailed information memorandum is available to qualified parties, copy and paste this link to complete the confidentiality agreement - https://forms.gle/69qVEPYg5KsB3UVKA
免责声明
广告资料由广告发布者或其代表提供，本平台并未对有关资料进行独立核实。 用户在作出任何决定、付款或承诺前，应自行核实所有资料并进行适当的尽职调查。
所有沟通、协议、交易、争议及索赔仅由相关各方自行负责。
了解如何防范诈骗